(Q37661014)

21 August 2017

Vitamin E treatment in patients with nonalcoholic steatohepatitis: A six-month, open-label study of sixteen patients (English)

1 reference

21 August 2017

0 references

0 references

Fahri Yakaryilmaz

1

1 reference

21 August 2017

Sefa Guliter

2

1 reference

21 August 2017

Seren Ozenirler

3

1 reference

21 August 2017

Ozlem Erdem

4

1 reference

21 August 2017

Gulen Akyol

5

1 reference

21 August 2017

1 May 2004

1 reference

Current Therapeutic Research

21 August 2017

1 reference

21 August 2017

65

1 reference

21 August 2017

3

1 reference

21 August 2017

266-277

1 reference

Treatment of non-alcoholic steatohepatitis

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Mitochondria in steatohepatitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic steatohepatitis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic steatohepatitis: a study of 49 patients

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Probucol in the treatment of non-alcoholic steatohepatitis: a double-blind randomized controlled study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Metformin in non-alcoholic steatohepatitis.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3964547

Nonalcoholic steatohepatitis

1 September 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

Nonalcoholic Steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid compositions in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0011-393X%2804%2980077-8

10.1016/S0011-393X(04)80077-8

7 January 2021

Identifiers

DOI

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24672082

1 reference